Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 12,931.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,931.44% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 2,679.34% |
WW International, Inc Common Stock (WW) | 1,954.2% |
DeFi Development (DFDV) | 1,937.45% |
Abivax SA American Depositary Shares (ABVX) | 1,180.8% |
Oncology Institute (TOI) | 1,148.37% |
FiEE (FIEE) | 1,023.85% |
Abits (ABTS) | 885.89% |
Above Food Ingredients Inc Common Stock (ABVE) | 860% |
180 Life Sciences (ATNF) | 838.55% |
Nanobiotix (NBTX) | 723.15% |
Lizhi (SOGP) | 722.63% |
Nova Lifestyle I (NVFY) | 721.48% |
Global Interactive Technologies (GITS) | 646.89% |
TMC the metals (TMC) | 618.42% |
Better Home & Finance (BETR) | 591.97% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 586.82% |
I-Mab (IMAB) | 578.82% |
mF International Limited Ordinary Shares (MFI) | 566.01% |
Epsium Enterprise Limited Ordinary Shares (EPSM) | 546.88% |
ThredUp (TDUP) | 532.64% |
Palvella Therapeutics (PVLA) | 530.06% |
Eightco (OCTO) | 514.9% |
Dominari (DOMH) | 508.4% |
